Lee C L, Zhou X L, Kudchadker R J, Harmon F, Harker Y D
Department of Nuclear Engineering, Massachusetts Institute of Technology, Cambridge 02139, USA.
Med Phys. 2000 Jan;27(1):192-202. doi: 10.1118/1.598884.
Advanced methods of boron neutron capture therapy (BNCT) use an epithermal neutron beam in conjunction with tumor-targeting boron compounds for irradiation of glioblastomas and metastatic melanomas. A common neutron-producing reaction considered for accelerator-based BNCT is 7Li(p,n)7Be, whose cross section increases very rapidly within several tens of keV of the reaction threshold at 1.88 MeV. Operation in the proton energy region near threshold will have an appreciable thick target neutron yield, but the neutrons produced will have relatively low energies that require little moderation to reach the epithermal range desirable for BNCT. Because of its relatively low projected accelerator cost and the portability of the neutron source/target assembly, BNCT based on the near-threshold technique is considered an attractive candidate for widespread hospital use. A systematic Monte Carlo N-Particle (MCNP) investigation of the dosimetric properties of near-threshold neutron beams has been performed. Results of these studies indicate that accelerator proton energies between 1.93 and 1.99 MeV, using 5 cm of H2O moderator followed by thin 6Li and Pb shields, can provide therapeutically useful beams with treatment times less than one hour and accelerator currents less than 5 mA.
硼中子俘获疗法(BNCT)的先进方法使用超热中子束与肿瘤靶向硼化合物联合用于照射胶质母细胞瘤和转移性黑色素瘤。基于加速器的BNCT所考虑的一种常见中子产生反应是7Li(p,n)7Be,其截面在1.88 MeV的反应阈值几十keV范围内迅速增加。在接近阈值的质子能量区域运行将有可观的厚靶中子产额,但产生的中子能量相对较低,几乎不需要慢化就能达到BNCT所需的超热范围。由于其预计的加速器成本相对较低以及中子源/靶组件的便携性,基于近阈值技术的BNCT被认为是广泛应用于医院的有吸引力的候选方案。已经对近阈值中子束的剂量学特性进行了系统的蒙特卡罗N粒子(MCNP)研究。这些研究结果表明,加速器质子能量在1.93至1.99 MeV之间,使用5 cm的H2O慢化剂,随后是薄的6Li和Pb屏蔽,可以提供治疗有用的束流,治疗时间小于一小时,加速器电流小于5 mA。